Astrazeneca Plc logo

AZN

Astrazeneca Plc

$68.94

Earnings Summary

Revenue
$11416Mn
Net Profits
$1818Mn
Net Profit Margins
15.93%

Highlights

Revenue:

Astrazeneca Plc’s revenue jumped 5.99% since last year same period to $11416Mn in the Q2 2023. On a quarterly growth basis, Astrazeneca Plc has generated 4.94% jump in its revenue since last 3-months.

Net Profits:

Astrazeneca Plc’s net profit jumped 405% since last year same period to $1818Mn in the Q2 2023. On a quarterly growth basis, Astrazeneca Plc has generated 0.83% jump in its net profits since last 3-months.

Net Profit Margins:

Astrazeneca Plc’s net profit margin jumped 376.47% since last year same period to 15.93% in the Q2 2023. On a quarterly growth basis, Astrazeneca Plc has generated -3.91% fall in its net profit margins since last 3-months.

Earnings per share (EPS) Estimates

Earnings per share (EPS) estimates of the Astrazeneca Plc post its latest quarter earnings

EPS Estimate Current Quarter
0.9
EPS Estimate Current Year
0.9

Highlights

EPS Estimate Current Quarter:

Astrazeneca Plc’s earning per share (EPS) estimates for the current quarter stand at 0.9 - a 4.75% jump from last quarter’s estimates.

EPS Estimate Current Year:

Astrazeneca Plc’s earning per share (EPS) estimates for the current year stand at 0.9.

Key Ratios

Key ratios of the Astrazeneca Plc post its Q3 2023 earnings

Earning Per Share (EPS)
0
Dividend Per Share (DPS)
0.47

Highlights

Earning Per Share (EPS):

Astrazeneca Plc’s earning per share (EPS) fell -100% since last year same period to 0 in the Q3 2023. This indicates that the Astrazeneca Plc has generated -100% annual rate of fall in its earning per share (EPS) in the last 4 quarters.

Dividend Per Share (DPS):

Astrazeneca Plc declared 0.47 dividend per share during the earnings announcement for Q3 2023.

Earnings Calendar

Earnings DateEstimated EPSReported EPSSurprise %
2023-11-09
0.9
0
-100%
2023-03-31
0.88
0
-100%
2023-06-30
0.86
0
-100%